Equity Capital And Reserves változás Dátum
Agilent USD 6.19B 343M 2023-12
AstraZeneca USD 37.2B 195M 2023-09
Bristol-Myers Squibb USD 29B 2.98B 2023-09
Bruker USD 1.39B 185.9M 2023-12
Catalent USD 3.69B 154M 2023-12
Centene USD 25.3B 376M 2023-09
Charles River Laboratories USD 3.6B 290.89M 2023-12
Cigna USD 45.69B 246M 2023-09
Danaher USD 53.49B 1.08B 2023-12
Dentsply International USD 3.29B 82M 2023-12
Elevance Health USD 39.31B 883M 2023-12
Eli Lilly USD 11.22B 156.6M 2023-09
Hologic USD 4.65B 363.1M 2023-12
Humana USD 16.26B 687M 2023-12
Illumina USD 5.74B 153M 2023-12
Intuitive Surgical USD 13.4B 858.3M 2023-12
IQVIA Holdings USD 6.11B 307M 2023-12
J&J USD 71.23B 3.92B 2023-09
Laboratory Of America USD 7.88B 1.9M 2023-12
Lonza CHF 10.31B 291M 2023-06
McKesson USD -1828000000 226M 2023-09
Merck EUR 28.22B 1.52B 2023-09
Merck USD 41.25B 2.55B 2023-09
Mettler Toledo International USD -149938000 44.07M 2023-12
Pfizer USD 96.93B 2.08B 2023-09
Quest Diagnostics USD 6.31B 118M 2023-12
Repligen USD 1.97B 17.35M 2023-12
Revvity USD 7.87B 178.46M 2023-12
Roche Holding CHF 26.52B 1.48B 2023-06
Supernus Pharmaceuticals USD 921.52M 9.32M 2023-12
Thermo Fisher Scientific USD 46.72B 1.4B 2023-12
UnitedHealth USD 94.42B 9.93B 2023-12
Veradigm USD 1.18B 19.32M 2022-09
Waters USD 905.52M 134.29M 2023-09
West Pharmaceutical Services USD 2.88B 12.8M 2023-12



Catalent A Saját Tőke És A Tartalékok - Az oldal aktuális és múlbeli adatokat, elorejelzéseket, statisztikákat, grafikonokat és a gazdasági naptár adatait tartalmazza - Mar 2024.